全文获取类型
收费全文 | 5031篇 |
免费 | 445篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 162篇 |
妇产科学 | 184篇 |
基础医学 | 481篇 |
口腔科学 | 77篇 |
临床医学 | 959篇 |
内科学 | 942篇 |
皮肤病学 | 47篇 |
神经病学 | 486篇 |
特种医学 | 76篇 |
外科学 | 428篇 |
综合类 | 52篇 |
一般理论 | 7篇 |
预防医学 | 732篇 |
眼科学 | 50篇 |
药学 | 476篇 |
中国医学 | 7篇 |
肿瘤学 | 286篇 |
出版年
2023年 | 29篇 |
2022年 | 38篇 |
2021年 | 95篇 |
2020年 | 60篇 |
2019年 | 85篇 |
2018年 | 112篇 |
2017年 | 99篇 |
2016年 | 118篇 |
2015年 | 117篇 |
2014年 | 158篇 |
2013年 | 232篇 |
2012年 | 337篇 |
2011年 | 379篇 |
2010年 | 210篇 |
2009年 | 169篇 |
2008年 | 320篇 |
2007年 | 383篇 |
2006年 | 405篇 |
2005年 | 345篇 |
2004年 | 307篇 |
2003年 | 266篇 |
2002年 | 257篇 |
2001年 | 75篇 |
2000年 | 75篇 |
1999年 | 77篇 |
1998年 | 42篇 |
1997年 | 29篇 |
1996年 | 34篇 |
1995年 | 31篇 |
1994年 | 21篇 |
1993年 | 21篇 |
1992年 | 36篇 |
1991年 | 37篇 |
1990年 | 30篇 |
1989年 | 30篇 |
1988年 | 28篇 |
1987年 | 23篇 |
1986年 | 35篇 |
1985年 | 37篇 |
1984年 | 27篇 |
1983年 | 20篇 |
1982年 | 20篇 |
1979年 | 30篇 |
1978年 | 15篇 |
1977年 | 16篇 |
1976年 | 15篇 |
1975年 | 20篇 |
1974年 | 19篇 |
1973年 | 18篇 |
1972年 | 15篇 |
排序方式: 共有5482条查询结果,搜索用时 15 毫秒
91.
Disrupted in schizophrenia 1 (DISC1) is well established as a genetic risk factor across a spectrum of psychiatric disorders, a role supported by a growing body of biological studies, making the DISC1 protein interaction network an attractive therapeutic target. By contrast, there is a relative deficit of structural information to relate to the myriad biological functions of DISC1. Here, we critically appraise the available bioinformatics and biochemical analyses on DISC1 and key interacting proteins, and integrate this with the genetic and biological data. We review, analyze, and make predictions regarding the secondary structure and propensity for disordered regions within DISC1, its protein-interaction domains, subcellular localization motifs, and the structural and functional implications of common and ultrarare DISC1 variants associated with major mental illness. We discuss signaling pathways of high pharmacological potential wherein DISC1 participates, including those involving phosphodiesterase 4 (PDE4) and glycogen synthase kinase 3 (GSK3). These predictions and priority areas can inform future research in the translational and potentially guide the therapeutic processes. 相似文献
92.
93.
94.
BKV‐specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA‐haploidentical haematopoietic cell transplantation 下载免费PDF全文
95.
96.
Unusual 1H NMR chemical shifts support (His) C(epsilon) 1...O==C H-bond: proposal for reaction-driven ring flip mechanism in serine protease catalysis 下载免费PDF全文
Ash EL Sudmeier JL Day RM Vincent M Torchilin EV Haddad KC Bradshaw EM Sanford DG Bachovchin WW 《Proceedings of the National Academy of Sciences of the United States of America》2000,97(19):10371-10376
13C-selective NMR, combined with inhibitor perturbation experiments, shows that the C(epsilon)(1)H proton of the catalytic histidine in resting alpha-lytic protease and subtilisin BPN' resonates, when protonated, at 9.22 ppm and 9.18 ppm, respectively, which is outside the normal range for such protons and approximately 0.6 to 0.8 ppm further downfield than previously reported. They also show that the previous alpha-lytic protease assignments [Markley, J. L., Neves, D. E., Westler, W. M., Ibanez, I. B., Porubcan, M. A. & Baillargeon, M. W. (1980) Front. Protein Chem. 10, 31-61] were to signals from inactive or denatured protein. Simulations of linewidth vs. pH demonstrate that the true signal is more difficult to detect than corresponding signals from inactive derivatives, owing to higher imidazole pK(a) values and larger chemical shift differences between protonated and neutral forms. A compilation and analysis of available NMR data indicates that the true C(epsilon)(1)H signals from other serine proteases are similarly displaced downfield, with past assignments to more upfield signals probably in error. The downfield displacement of these proton resonances is shown to be consistent with an H-bond involving the histidine C(epsilon)(1)H as donor, confirming the original hypothesis of Derewenda et al. [Derewenda, Z. S., Derewenda, U. & Kobos, P. M. (1994) J. Mol. Biol. 241, 83-93], which was based on an analysis of literature x-ray crystal structures of serine hydrolases. The invariability of this H-bond among enzymes containing Asp-His-Ser triads indicates functional importance. Here, we propose that it enables a reaction-driven imidazole ring flip mechanism, overcoming a major dilemma inherent in all previous mechanisms, namely how these enzymes catalyze both the formation and productive breakdown of tetrahedral intermediates. 相似文献
97.
98.
Tai YT Dillon M Song W Leiba M Li XF Burger P Lee AI Podar K Hideshima T Rice AG van Abbema A Jesaitis L Caras I Law D Weller E Xie W Richardson P Munshi NC Mathiot C Avet-Loiseau H Afar DE Anderson KC 《Blood》2008,112(4):1329-1337
Currently, no approved monoclonal antibody (mAb) therapies exist for human multiple myeloma (MM). Here we characterized cell surface CS1 as a novel MM antigen and further investigated the potential therapeutic utility of HuLuc63, a humanized anti-CS1 mAb, for treating human MM. CS1 mRNA and protein was highly expressed in CD138-purified primary tumor cells from the majority of MM patients (more than 97%) with low levels of circulating CS1 detectable in MM patient sera, but not in healthy donors. CS1 was expressed at adhesion-promoting uropod membranes of polarized MM cells, and short interfering RNA (siRNA) targeted to CS1 inhibited MM cell adhesion to bone marrow stromal cells (BMSCs). HuLuc63 inhibited MM cell binding to BMSCs and induced antibody-dependent cellular cytotoxicity (ADCC) against MM cells in dose-dependent and CS1-specific manners. HuLuc63 triggered autologous ADCC against primary MM cells resistant to conventional or novel therapies, including bortezomib and HSP90 inhibitor; and pretreatment with conventional or novel anti-MM drugs markedly enhanced HuLuc63-induced MM cell lysis. Administration of HuLuc63 significantly induces tumor regression in multiple xenograft models of human MM. These results thus define the functional significance of CS1 in MM and provide the preclinical rationale for testing HuLuc63 in clinical trials, either alone or in combination. 相似文献
99.
100.
John M Conly H Grant Stiver Karl A Weiss Debbie L Becker Andrew J Rosner Elizabeth Miller 《The Canadian Journal of Infectious Diseases & Medical Microbiology》2003,14(6):315-321